Elicio Therapeutics appoints CEO Robert Connelly as Principal Financial and Accounting Officer

Elicio Therapeutics, Inc.

Robert Connelly, already CEO and President, appointed as Principal Accounting Officer and Principal Financial Officer effective Oct 15, 2024.
Connelly has nearly 40 years of life science leadership; previously CEO of Axcella Health, Pulmatrix, and Domantis (acquired by GSK).
No family relationships with other directors or executive officers; no reportable transactions under Item 404(a).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert Connelly

Principal Accounting Officer and Principal Financial Officer

ELTX · Elicio Therapeutics, Inc.

Effective: 2024-10-15
Filed: October 17, 2024, 7:59 PM ET

On October 15, 2024 , Elicio Therapeutics, Inc. (the “Company”) appointed Robert Connelly as the Company’s Principal Accounting Officer and Principal Financial Officer effective October 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Connelly was appointed as Principal Accounting Officer and Principal Financial Officer at Elicio Therapeutics, Inc..

Action: appointed
Role: Principal Accounting Officer and Principal Financial Officer

Exact text from the filing

On October 15, 2024 , Elicio Therapeutics, Inc. (the “Company”) appointed Robert Connelly as the Company’s Principal Accounting Officer and Principal Financial Officer effective October 15, 2024.

View on SEC.gov

Elicio Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001601485-24-000057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.